Skip to content

Bruker BRKR Current Debt

Current Debt at other companies

Danaher logo
DanaherDHR
$923M+84.2%
Agilent Technologies logo
Agilent TechnologiesA
$304M+108%
Revvity logo
RevvityRVTY
$575.83M+237,847%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$7M-99.7%
IDEX logo
IDEXIEX
$500K-99.5%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's current debt?
Bruker (BRKR) reported current debt of $8.4M in Q1 2026.
How has Bruker's current debt changed year-over-year?
Bruker's current debt decreased by 77.7% year-over-year, from $37.7M to $8.4M.
What is the long-term trend for Bruker's current debt?
Over 5 years (2020 to 2025), Bruker's current debt has grown at a 49.8% compound annual growth rate (CAGR), from $2.2M to $16.6M.
What does current debt mean?
The amount of long-term debt that must be paid back within one year.
How do you interpret current debt?
An increase indicates higher short-term cash outflow requirements, potentially straining liquidity if not managed with sufficient cash reserves.
How does current debt compare across companies?
Standard across all public companies; high levels relative to cash flow may signal refinancing risk.